Our Clinical Trial
We advocate immunotherapy strategies that are very specific, eradicating the tumor without hurting any other part of the patient. Immunotherapy is the process by which we help the immune system see a tumor as something harmful that should be destroyed.
Our goal is to open and fund a clinical trial that will focus on the four following poor-prognosis pediatric brain cancers:
-
AT/RT Atypical Teratoid Rhabdoid Tumor
-
High grade glioblastoma (HGG)
-
High risk medullablastoma
-
High risk ependymoma
The prognoses for these cancers are very poor and children diagnosed with these cancers often turn to clinical trials like this one to give them the best chance possible to fight this disease.
Children that are ultimately enrolled in our clinical trial will receive the current recommended treatment for their particular cancer, plus customized immunotherapy.
Our research on immunotherapy for cancer treatment has revealed promising discoveries and results and with your help we will help children fight cancer with the powerful resource of immunotherapy.